Want to see CTEV full AI Analyst Report?
CTEV Stock Chart & Stats
$21.61
$0.21(0.97%)
At close: 4:00 PM EDT
$21.61
$0.21(0.97%)
Day’s Range― - ―
52-Week Range$11.50 - $74.07
Previous Close$21.82
Volume81.92K
Average Volume (3M)120.62K
Market Cap
$387.16M
Enterprise Value$4.98K
Total Cash (Recent Filing)$14.37M
Total Debt (Recent Filing)$4.62B
Price to Earnings (P/E)―
Beta2.17
Next Earnings
Nov 10, 2026EPS Estimate
-3.81Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-17.00
Shares Outstanding17,047,789
10 Day Avg. Volume124,087
30 Day Avg. Volume120,620
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-4.04
Price to Sales (P/S)0.73
P/FCF Ratio-57.23
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$41.50Price Target Upside92.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-15.93
Revenue Forecast (FY)$993.39M
Bulls Say, Bears Say
Bulls Say
Bookings Momentum And Large PipelineSustained ACV bookings growth and a >$300M pipeline with >3x coverage provide a durable revenue lead indicator. With management noting typical 2–4 quarter first-dollar conversion and further annualization, this supports multi-quarter revenue compounding, larger deal sizes, and predictable future cash conversion.
Revenue Rebound With Strong Core MarginsA significant TTM revenue rebound paired with mid-single-digit operating margin and very high EBITDA margin suggests scalable operations and pricing power in core services. Durable margin structure supports reinvestment into tech and sales, improving long-term break-even and cash generation potential.
Improving Cash Generation And Working CapitalPositive operating cash flow and quarter-over-quarter cash improvements indicate the business is converting operations into liquidity. Improved DSO/DPO by >5 days and record levered FCF show operational leverage and working-capital gains that can sustainably fund operations and reduce near-term refinancing pressure.
Bears Say
High Leverage And Negative EquityMaterial leverage and negative shareholder equity directly constrain financial flexibility. This capital-structure impairment increases refinancing risk, elevates interest burden, and limits the company's ability to invest or absorb shocks, making durable operational gains harder to translate into balance-sheet repair.
Persistent Net Losses And Volatile ProfitabilityDespite operating and EBITDA improvement, sustained TTM net losses and swings in profitability weaken free cash flow durability and capital accumulation. Ongoing bottom-line deficits impede equity rebuilding and raise dependency on external financing, making long-term deleveraging and value creation uncertain.
Ongoing DOJ Civil Antitrust InquiryAn active civil investigative demand from the DOJ introduces legal, compliance and contract-risk overhangs. Potential remedies, fines, or operational restrictions could require costly remediation, divert management focus, and slow enterprise sales where regulatory trust and contract approvals matter over multiple quarters.
Claritev News
CTEV FAQ
What was Claritev Corporation’s price range in the past 12 months?
Claritev Corporation lowest stock price was $11.50 and its highest was $74.07 in the past 12 months.
What is Claritev Corporation’s market cap?
Claritev Corporation’s market cap is $387.16M.
When is Claritev Corporation’s upcoming earnings report date?
Claritev Corporation’s upcoming earnings report date is Nov 10, 2026 which is in 93 days.
How were Claritev Corporation’s earnings last quarter?
Claritev Corporation released its earnings results on Aug 07, 2026. The company reported -$3.49 earnings per share for the quarter, beating the consensus estimate of -$4.121 by $0.631.
Is Claritev Corporation overvalued?
According to Wall Street analysts Claritev Corporation’s price is currently Undervalued.
Does Claritev Corporation pay dividends?
Claritev Corporation does not currently pay dividends.
What is Claritev Corporation’s EPS estimate?
Claritev Corporation’s EPS estimate is -3.81.
How many shares outstanding does Claritev Corporation have?
Claritev Corporation has 17,047,789 shares outstanding.
What happened to Claritev Corporation’s price movement after its last earnings report?
Claritev Corporation reported an EPS of -$3.49 in its last earnings report, beating expectations of -$4.121. Following the earnings report the stock price went up 21.423%.
Which hedge fund is a major shareholder of Claritev Corporation?
Currently, no hedge funds are holding shares in CTEV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Claritev Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.50 (92.04% Upside)
$41.50 (92.04% Upside)
Blogger Sentiment
Neutral
CTEV Sentiment 67%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 61.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $493.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.8%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.82%
Trailing 12-Months
Company Description
Claritev Corporation
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
CTEV Company Deck
CTEV Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: multi-quarter revenue growth, record/near-record EBITDA and cash flow, significant bookings acceleration and a substantially enlarged pipeline. Management raised revenue and EBITDA guidance and highlighted successful execution across TPA, Claims Intelligence and AI-enabled initiatives. Offsetting considerations include timing and mix-driven pressure on revenue per claim, network comparables impacted by prior-year one-time items, a near-term Payments timing miss, and some volume/regulatory uncertainty that introduces short-term variability. Overall, the positive metrics and trajectory substantially outweigh the manageable timing and mix headwinds.View all CTEV earnings summariesCTEV Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$41.50
▲(92.04% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
16.89% Insiders
29.69% Mutual Funds
4.98% Other Institutional Investors
41.75% Public Companies and
Individual Investors









